Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohort
•Our blinded analysis of HCC recurrence following “curative” treatment:•Argues against the “curative” efficacy of the first treatment of HCC in one third of patients.•Evidences that DAA therapy has no significant impact on the severity or progression of HCC recurrence.•Evidences that DAA therapy doe...
Gespeichert in:
Veröffentlicht in: | Clinics and research in hepatology and gastroenterology 2021-01, Vol.45 (1), p.101459-101459, Article 101459 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!